Lung Cancer | Proceedings from a daylong symposium hosted in partnership with Florida Cancer Specialists – Part 2: Lung Cancer

Proceedings from a daylong symposium hosted in partnership with Florida Cancer Specialists, featuring key clinical presentations and papers in lung cancer. Featuring perspectives from Drs Lecia Sequist and David Spigel, including the following topics: Introduction Case: A woman in her early 70s with microsatellite stable metastatic adenocarcinoma of the lung and a HER2 mutation, PD-L1 TPS 0% — Dr Zafar Case: A man in his mid-80s with localized adenocarcinoma of the lung and an EGFR exon 19 deletion — Dr Gandhi Case: A woman in her late 70s with metastatic adenocarcinoma of the lung, somatic BRCA2 and KRAS G12C mutations and high tumor mutation burden (TMB) — Kapisthalam (KS) Kumar, MD Targeted Therapy for Lung Cancer Chalk Talk — Dr Spigel Case: A man in his mid-60s with Stage IIIA (8-cm, node-negative) adenocarcinoma of the lung — Shachar Peles, MD Case: A man in his mid-50s with Stage IIIA adenocarcinoma of the lung — Dr Choksi Case: A woman in her mid-60s with metastatic adenocarcinoma of the lung, PD-L1 56% — Dr Gandhi First-Line Treatment of PD-L1-Negative Metastatic NSCLC without a Targetable Mutation Chalk Talk — Dr Sequist Selecting Patients with Localized NSCLC for Adjuvant Immunotherapy Chalk Talk — Dr Spigel Case: A man in his early 50s with extensive-stage small cell lung cancer (SCLC) — Dr Apuri Case: A man in his mid-60s with extensive-stage SCLC and concurrent prostate cancer — Dr Gandhi CME information and select publications